Sage Publications Ltd.

SHERPA: Unknown

People

  1. Jhaveri
    Jhaveri
  2. Dang
    Dang
  3. Goldfarb
    Goldfarb
  4. Hudis
    Hudis
  5. Modi
    Modi
  6. Razavi
    Razavi

Groups

  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (6)
  4. Survivorship Research (2)
  5. Epidemiology and Biostatistics (1)
  6. Health Outcomes Research Group (1)
  7. Population Sciences Research Program (1)
  8. Weinberg Fellows (1)
Search Within
  1. "Breast Medicine Service"
Formats
  1. Journal Article (3)
  2. Review (3)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (6)
  4. Survivorship Research (2)
  5. Epidemiology and Biostatistics (1)
  6. Health Outcomes Research Group (1)

More Groups

People
  1. Komal Jhaveri (2)
  2. Chau Dang (1)
  3. Clifford Hudis (1)
  4. Maura Dickler (1)
  5. Pedram Razavi (1)
  6. Shanu Modi (1)

More People

Years
  1. 2023 (4)
  2. 2022 (1)
  3. 2011 (1)
Publications
  1. Therapeutic Advances in Medical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer
    Review

    Pegram, M.; Pietras, R.; Dang, C. T.; Murthy, R.; Bachelot, T.; Janni, W.; Sharma, P.; Hamilton, E.; Saura, C.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Targeting HER2-low in metastatic breast cancer: An evolving treatment paradigm
    Review

    Yang, C.; Brezden-Masley, C.; Joy, A. A.; Sehdev, S.; Modi, S.; Simmons, C.; Henning, J. W.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: A matching-adjusted indirect comparison
    Journal Article

    Rugo, H. S.; Harmer, V.; O’Shaughnessy, J.; Jhaveri, K.; Tolaney, S. M.; Cardoso, F.; Bardia, A.; Maheshwari, V. K.; Tripathi, S.; Haftchenary, S.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: Current and emerging role
    Review

    Lloyd, M. R.; Wander, S. A.; Hamilton, E.; Razavi, P.; Bardia, A.
    Therapeutic Advances in Medical Oncology (2022)

    Fulltext@MSK | Save
  • Bevacizumab in metastatic breast cancer: When may it be used?
    Journal Article

    Goldfarb, S. B.; Hudis, C.; Dickler, M. N.
    Therapeutic Advances in Medical Oncology (2011)

    Fulltext@MSK | Save

    • Sage Publications Ltd. – authorized name for: